# China NMPA Inspection - Guangxi Jinshengtang Biotechnology Co., Ltd. - September 10, 2021

Source: https://www.globalkeysolutions.net/records/china_inspection/guangxi-jinshengtang-biotechnology-co-ltd/5651c324-8f6d-4fae-83e1-b84ece70679f/
Source feed: China

> China NMPA unannounced inspection for Guangxi Jinshengtang Biotechnology Co., Ltd. published September 10, 2021. On September 10, 2021, the Guangxi Zhuang Autonomous Region Drug Administration publicly released the results of unannounced inspections conducted on 

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement of the Results of Supervision and Inspection of Cosmetic Manufacturers in Guangxi Zhuang Autonomous Region (Issue 2, 2021)
- Company Name: Guangxi Jinshengtang Biotechnology Co., Ltd.
- Publication Date: 2021-09-10
- Product Type: cosmetics
- Summary: On September 10, 2021, the Guangxi Zhuang Autonomous Region Drug Administration publicly released the results of unannounced inspections conducted on numerous licensed cosmetics manufacturers operating within its region. These comprehensive inspections were initiated as part of the 2021 regional cosmetics supervision work plan, an initiative designed to reinforce regulatory oversight and ensure the quality and safety of cosmetic products. The announcement specifically identifies 27 companies that underwent scrutiny, including prominent names such as Guangxi Jinshengtang Biotechnology Co., Ltd., Guangxi Wanhao Biotechnology Co., Ltd., and Nanning Daxumei Cosmetics Co., Ltd., along with many others. The full details regarding any identified violations or necessary corrective actions for each individual company are contained within separate, attached inspection reports, which are not provided in this summary document. Therefore, specific main violations and required actions are not enumerated here but are expected to be addressed by the respective manufacturers. The regulatory framework underpinning these inspections stems from the regional drug administration's mandate, operating under the broader authority and guidelines of China's National Medical Products Administration (NMPA). This announcement serves to inform the public and ensure transparency in regulatory enforcement within the cosmetics sector.

Company: https://www.globalkeysolutions.net/companies/guangxi-jinshengtang-biotechnology-co-ltd/b64ad955-c1f5-42f0-ac5e-872d91d5891d/